Adenoviruses in lymphocytes of the human gastro-intestinal tract

PLoS ONE

Volumn 6, Issue 9, 2011, Pages

  Roy, Soumitra ^a,b   Calcedo, Roberto ^a   Medina Jaszek, Angelica ^a   Keough, Martin ^a   Peng, Hui ^a   Wilson, James M ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b CRUCELL HOLLAND BV   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA; VIRUS DNA;

ADENOVIRUS; ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CONTROLLED STUDY; DNA SEQUENCE; GASTROINTESTINAL TRACT; GENE DOSAGE; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; INTESTINE FLORA; LAMINA PROPRIA; LYMPHOCYTE; POLYMERASE CHAIN REACTION; VIRUS GENE; ADENOVIRUS INFECTION; AGED; CELL FRACTIONATION; CYTOLOGY; GENETICS; MALE; METABOLISM; METHODOLOGY; MIDDLE AGED; MOLECULAR GENETICS; NUCLEOTIDE SEQUENCE; PHYLOGENY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEQUENCE HOMOLOGY; VIROLOGY;

ADENOVIRIDAE; ADENOVIRIDAE INFECTIONS; AGED; BASE SEQUENCE; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; GASTROINTESTINAL TRACT; HUMANS; LYMPHOCYTES; MALE; MIDDLE AGED; MOLECULAR SEQUENCE DATA; PHYLOGENY; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SEQUENCE HOMOLOGY, NUCLEIC ACID; SUBCELLULAR FRACTIONS;

EID: 80053611414     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0024859     Document Type: Article

References (37)

1. Fox JP, Brandt CD, Wassermann FE, Hall CE, Spigland I, et al. (1969) The virus watch program: a continuing surveillance of viral infections in metropolitan New York families. VI. Observations of adenovirus infections: virus excretion patterns, antibody response, efficiency of surveillance, patterns of infections, and relation to illness. Am J Epidemiol 89: 25-50.
2. Fox JP, Hall CE, Cooney MK, (1977) The Seattle Virus Watch. VII. Observations of adenovirus infections. Am J Epidemiol 105: 362-386.
3. Evans AS, (1958) Latent adenovirus infections of the human respiratory tract. Am J Hyg 67: 256-266.
4. Rowe WP, Huebner RJ, Gilmore LK, Parrott RH, Ward TG, (1953) Isolation of a cytopathogenic agent from human adenoids undergoing spontaneous degeneration in tissue culture. Proc Soc Exp Biol Med 84: 570-573.
5. Strohl WA, Schlesinger RW, (1965) Quantitative Studies of Natural and Experimental Adenovirus Infections of Human Cells. I. Characteristics of Viral Multiplication in Fibroblasts Derived by Long-Term Culture from Tonsils. Virology 26: 199-207.
6. van der Veen J, Lambriex M, (1973) Relationship of adenovirus to lymphocytes in naturally infected human tonsils and adenoids. Infect Immun 7: 604-609.
7. Neumann R, Genersch E, Eggers HJ, (1987) Detection of adenovirus nucleic acid sequences in human tonsils in the absence of infectious virus. Virus Res 7: 93-97.
8. Garnett CT, Erdman D, Xu W, Gooding LR, (2002) Prevalence and quantitation of species C adenovirus DNA in human mucosal lymphocytes. J Virol 76: 10608-10616.
9. Garnett CT, Talekar G, Mahr JA, Huang W, Zhang Y, et al. (2009) Latent species C adenoviruses in human tonsil tissues. J Virol 83: 2417-2428.
10. Durepaire N, Rogez JP, Verdier M, Rogez S, Weinbreck P, et al. (1997) Detection of adenovirus DNA by polymerase chain reaction in peripheral blood lymphocytes from HIV-infected patients and a control group: preliminary results. J Acquir Immune Defic Syndr Hum Retrovirol 14: 189-190.
11. Flomenberg P, Gutierrez E, Piaskowski V, Casper JT, (1997) Detection of adenovirus DNA in peripheral blood mononuclear cells by polymerase chain reaction assay. J Med Virol 51: 182-188.
12. Echavarria M, (2008) Adenoviruses in immunocompromised hosts. Clin Microbiol Rev 21: 704-715.
13. Hierholzer JC, (1992) Adenoviruses in the immunocompromised host. Clin Microbiol Rev 5: 262-274.
14. Buchbinder SP, Mehrotra DV, Duerr A, Fitzgerald DW, Mogg R, et al. (2008) Efficacy assessment of a cell-mediated immunity HIV-1 vaccine (the Step Study): a double-blind, randomised, placebo-controlled, test-of-concept trial. Lancet 372: 1881-1893.
15. Lu S, (2008) Human versus HIV: round 2 defeat in AIDS vaccine development. Expert Rev Vaccines 7: 151-153.
16. Sekaly RP, (2008) The failed HIV Merck vaccine study: a step back or a launching point for future vaccine development? J Exp Med 205: 7-12.
17. Benlahrech A, Harris J, Meiser A, Papagatsias T, Hornig J, et al. (2009) Adenovirus vector vaccination induces expansion of memory CD4 T cells with a mucosal homing phenotype that are readily susceptible to HIV-1. Proc Natl Acad Sci U S A 106: 19940-19945.
18. Roy S, Vandenberghe LH, Kryazhimskiy S, Grant R, Calcedo R, et al. (2009) Isolation and characterization of adenoviruses persistently shed from the gastrointestinal tract of non-human primates. PLoS Pathog 5: e1000503.
19. Cunningham AL, Grohman GS, Harkness J, Law C, Marriott D, et al. (1988) Gastrointestinal viral infections in homosexual men who were symptomatic and seropositive for human immunodeficiency virus. J Infect Dis 158: 386-391.
20. Calcedo R, Vandenberghe LH, Roy S, Somanathan S, Wang L, et al. (2009) Host immune responses to chronic adenovirus infections in human and nonhuman primates. J Virol 83: 2623-2631.
21. Saitou N, Nei M, (1987) The neighbor-joining method: a new method for reconstructing phylogenetic trees. Mol Biol Evol 4: 406-425.
22. Horvath J, Palkonyay L, Weber J, (1986) Group C adenovirus DNA sequences in human lymphoid cells. J Virol 59: 189-192.
23. Lavery D, Fu SM, Lufkin T, Chen-Kiang S, (1987) Productive infection of cultured human lymphoid cells by adenovirus. J Virol 61: 1466-1472.
24. Silver L, Anderson CW, (1988) Interaction of human adenovirus serotype 2 with human lymphoid cells. Virology 165: 377-387.
25. Wold WSM, Horwitz MS, (2007) Fields Virology; In: Knipe DM, Howley PM, editors. Lippincott, Williams and Wilkins pp. 2395-2436.
26. Adrian T, Schafer G, Cooney MK, Fox JP, Wigand R, (1988) Persistent enteral infections with adenovirus types 1 and 2 in infants: no evidence of reinfection. Epidemiol Infect 101: 503-509.
27. McManus TE, Marley AM, Baxter N, Christie SN, Elborn JS, et al. (2007) Acute and latent adenovirus in COPD. Respir Med 101: 2084-2090.
28. Zhang Y, Huang W, Ornelles DA, Gooding LR, (2010) Modeling adenovirus latency in human lymphocyte cell lines. J Virol 84: 8799-8810.
29. Chu Y, Sperber K, Mayer L, Hsu MT, (1992) Persistent infection of human adenovirus type 5 in human monocyte cell lines. Virology 188: 793-800.
30. McNees AL, Mahr JA, Ornelles D, Gooding LR, (2004) Postinternalization inhibition of adenovirus gene expression and infectious virus production in human T-cell lines. J Virol 78: 6955-6966.
31. Chen H, Xiang ZQ, Li Y, Kurupati RK, Jia B, et al. (2010) Adenovirus-based vaccines: comparison of vectors from three species of adenoviridae. J Virol 84: 10522-10532.
32. Hutnick NA, Carnathan D, Demers K, Makedonas G, Ertl HC, et al. (2010) Adenovirus-specific human T cells are pervasive, polyfunctional, and cross-reactive. Vaccine 28: 1932-1941.
33. Nwanegbo E, Vardas E, Gao W, Whittle H, Sun H, et al. (2004) Prevalence of neutralizing antibodies to adenoviral serotypes 5 and 35 in the adult populations of The Gambia, South Africa, and the United States. Clin Diagn Lab Immunol 11: 351-357.
34. Appaiahgari MB, Pandey RM, Vrati S, (2007) Seroprevalence of neutralizing antibodies to adenovirus type 5 among children in India: implications for recombinant adenovirus-based vaccines. Clin Vaccine Immunol 14: 1053-1055.
35. Thorner AR, Vogels R, Kaspers J, Weverling GJ, Holterman L, et al. (2006) Age dependence of adenovirus-specific neutralizing antibody titers in individuals from sub-Saharan Africa. J Clin Microbiol 44: 3781-3783.
36. Top FH Jr, Buescher EL, Bancroft WH, Russell PK, (1971) Immunization with live types 7 and 4 adenovirus vaccines. II. Antibody response and protective effect against acute respiratory disease due to adenovirus type 7. J Infect Dis 124: 155-160.
37. Tucker SN, Tingley DW, Scallan CD, (2008) Oral adenoviral-based vaccines: historical perspective and future opportunity. Expert Rev Vaccines 7: 25-31.